Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Ecological Niches

Ecological Niches

All organisms have a position within an ecosystem. The complete set of living and nonliving factors—including food resources, climate, and terrain—that define the position of a given organism are collectively referred to as the organism’s ecological niche.

Stem Cell Niche

Stem Cell Niche

The stem cell niche is the dynamic microenvironment where stem cells reside. Inside these niches, the cells may remain undifferentiated, undergo high self-renewal, or become lineage-specific progenitors. Stem cells coexist with other niche cells, such as stromal cells. They also interact closely with the ECM. Cell-cell and cell-matrix communication occur via adhesion molecules or soluble factors that signal the stem cells and determine their fate. Stromal cells also provide survival signals to...

Multipotency and Niche of Bulge Stem Cell

Multipotency and Niche of Bulge Stem Cell

A hair follicle or HF is a small part of the skin that produces the hair shaft. Paul Gerson Unna was the first to observe a bulge in the human hair follicle's outer root sheath (ORS). The bulge is present between the sebaceous gland and the arrector pili muscle and is the niche for hair follicle stem cells (HFSCs). The bulge is also a niche for melanocyte stem cells, and their loss results in graying of hair. The HFSCs express Sox9 and Lhx2, which help them maintain stemness and prevent...

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cuproptosis promotes antitumour immunity.

Nature reviews. Cancer·2026

Same author

Escaping the trap.

Nature reviews. Cancer·2026

Same author

Increasing TET Expression and 5-Hydroxymethylcytosine Formation by a Carbocyclic 5-Aza-2'-deoxy-cytidine Antimetabolite.

Angewandte Chemie (International ed. in English)·2026

Same author

Complementary efficacy of CD127-directed immunotherapy with lusvertikimab and ABL-targeting tyrosine kinase inhibitors in preclinical ABL-class-fusion-positive B-ALL.

HemaSphere·2026

Same author

AACR 2026.

Nature reviews. Cancer·2026

Same author

Author Correction: The ubiquitin ligase RNF5 determines acute myeloid leukemia growth and susceptibility to histone deacetylase inhibitors.

Nature communications·2026

Search research articles

Related Experiment Video

Updated: Jan 25, 2026

An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth

An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth

Published on: August 11, 2011

Tumor Cell Dormancy-Triggered by the Niche.

Daniela Senft¹, Irmela Jeremias²

¹Research Unit Apoptosis in Hematopoietic Stem Cells, Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Munich, Germany.

Developmental Cell

|May 8, 2019

Summary

Dormant cancer cells can survive treatments, leading to relapse. Bone marrow niche mechanisms regulating leukemia dormancy offer new targets for therapies aimed at eliminating these persistent tumor cells.

More Related Videos

Author Spotlight: Standardizing Limbal Niche Cell (LNC) Isolation and Characterization to Support Widespread LNC Research

Author Spotlight: Standardizing Limbal Niche Cell (LNC) Isolation and Characterization to Support Widespread LNC Research

Published on: October 27, 2023

Reliable Method for Assessing Seed Germination, Dormancy, and Mortality under Field Conditions

Reliable Method for Assessing Seed Germination, Dormancy, and Mortality under Field Conditions

Published on: November 6, 2016

Related Experiment Videos

Last Updated: Jan 25, 2026

An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth

An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth

Published on: August 11, 2011

Author Spotlight: Standardizing Limbal Niche Cell (LNC) Isolation and Characterization to Support Widespread LNC Research

Author Spotlight: Standardizing Limbal Niche Cell (LNC) Isolation and Characterization to Support Widespread LNC Research

Published on: October 27, 2023

Reliable Method for Assessing Seed Germination, Dormancy, and Mortality under Field Conditions

Reliable Method for Assessing Seed Germination, Dormancy, and Mortality under Field Conditions

Published on: November 6, 2016

Area of Science:

Hematology
Cancer Biology
Cellular Biology

Background:

Dormant cancer cells evade therapy, increasing relapse risk and poor prognosis.
The bone marrow niche plays a critical role in regulating cancer cell dormancy.
Understanding these niche interactions is crucial for developing effective cancer treatments.

Purpose of the Study:

To elucidate the mechanisms by which the bone marrow niche regulates leukemia cell dormancy.
To identify molecular targets within the niche for therapeutic intervention.
To provide a basis for developing novel therapies to eliminate dormant tumor cells.

Main Methods:

Review and synthesis of findings from two recent publications.
Analysis of molecular mechanisms governing cell dormancy in the bone marrow microenvironment.
Identification of potential therapeutic strategies targeting the niche.

Main Results:

Detailed description of specific mechanisms employed by the bone marrow niche to maintain leukemia cell dormancy.
Identification of key molecular players and pathways involved in niche-mediated dormancy.
Evidence supporting the potential for targeting the bone marrow niche to disrupt dormancy.

Conclusions:

The bone marrow niche actively regulates leukemia dormancy through specific molecular mechanisms.
Targeting these niche-dependent mechanisms offers a promising therapeutic strategy.
Eliminating dormant leukemia cells via niche-targeting therapies could improve patient outcomes and prevent relapse.